|
Widemann, Brigitte C; Goodspeed, Wendy; Goodwin, Anne et al. (2009) Phase I trial and pharmacokinetic study of ixabepilone administered daily for 5 days in children and adolescents with refractory solid tumors. J Clin Oncol 27:550-6
|
|
Abraham, Jame; Edgerly, Maureen; Wilson, Richard et al. (2009) A phase I study of the P-glycoprotein antagonist tariquidar in combination with vinorelbine. Clin Cancer Res 15:3574-82
|
|
Stein, Wilfred D; Litman, Thomas; Fojo, Tito et al. (2007) A database study that identifies genes whose expression correlates, negatively or positively, with 5-year survival of cancer patients. Biochim Biophys Acta 1770:857-71
|
|
Bates, Susan E; Rosing, Douglas R; Fojo, Tito et al. (2006) Challenges of evaluating the cardiac effects of anticancer agents. Clin Cancer Res 12:3871-4
|
|
Huff, Lyn M; Lee, Jong-Seok; Robey, Robert W et al. (2006) Characterization of gene rearrangements leading to activation of MDR-1. J Biol Chem 281:36501-9
|
|
Robey, Robert W; Zhan, Zhirong; Piekarz, Richard L et al. (2006) Increased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide (FR901228, FK228, NSC630176). Clin Cancer Res 12:1547-55
|
|
Piekarz, Richard L; Frye, A Robin; Wright, John J et al. (2006) Cardiac studies in patients treated with depsipeptide, FK228, in a phase II trial for T-cell lymphoma. Clin Cancer Res 12:3762-73
|
|
Rao, V Koneti; Knutsen, Turid; Ried, Thomas et al. (2005) The extent of chromosomal aberrations induced by chemotherapy in non-human primates depends on the schedule of administration. Mutat Res 583:105-19
|
|
Fojo, Antonio Tito (2005) Introduction: chemotherapies in the treatment of breast cancer. Semin Oncol 32:S1-2
|
|
Dean, Michael; Fojo, Tito; Bates, Susan (2005) Tumour stem cells and drug resistance. Nat Rev Cancer 5:275-84
|
Showing the most recent 10 out of 15 publications
